Therapies at Cipla
With our growing scientific understanding of rare diseases, we shall continue to introduce ground breaking therapies to give our patients their new beginnings!
From Care to Cure
Life at Cipla
Investor Centre
Stock Price Index
Turnover
$2.3 Billion
Latest Press Releases
Investor Resources
Employee stories
Hear it from the Cipla-ites!
César Useros Cubo
Cipla Europe, Spain
Came across this delightful video on #Instagram of this young talent - Affan Kutty, solving the Rubiks cube blindfolded in a tribute to @Cipla_Global! Cheers to his genius! https://t.co/vwwYEYSbf4

Cipla receives final @US_FDA approval for generic version of Novartis Pharmaceuticals Corporation's Durezol (Difluprednate Ophthalmic Emulsion 0.05%) https://t.co/Qx5WtfTANY https://t.co/SPjsYSPZmL
Join us at 3pm today - Aug 11th to see the power of innovation and collaboration in #Covid. The SAANS #facemask project completes a year. Hear from @csiriict, NGOs & from women & elderly members of SHGs across India. Live on Cipla Foundation's Facebook. https://t.co/C5siFQzVtq
Ms. @SaminaHamied, Executive Vice Chairperson, @Cipla_Global talks about 'How the industry is moving towards self-sufficiency to improve the accessibility of medicines.'Watch the video now!Full video: https://t.co/UWTlkCRtfm #COVID19 #Pharma #Medicines #Accessibility (1/3) https://t.co/tly8u4v6IJ